Cornerstone Advisors, LLC Merck & Co., Inc. Transaction History

Cornerstone Advisors, LLC

$2.51 Billion
Q3 2024

A detailed history of Cornerstone Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 131,000 shares of MRK stock, worth $12.8 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

131,000

Previous 131,000 -0.0%

Holding current value

$12.8 Million

Previous $16.2 Million 8.27%

% of portfolio

0.59%

Previous 0.66%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $45,296 - $52,779	400 Added 0.31%	131,000 $17.3 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $1.72 Million - $1.88 Million	-17,200 Reduced 11.64%	130,600 $14.2 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $4.62 Million - $5.13 Million	-44,900 Reduced 23.3%	147,800 $15.2 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $7.31 Million - $7.97 Million	-67,300 Reduced 25.88%	192,700 $22.2 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $6.18 Million - $6.89 Million	60,000 Added 30.0%	260,000 $27.7 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $5.09 Million - $6.52 Million	-58,200 Reduced 22.54%	200,000 $22.2 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $2.54 Million - $2.85 Million	30,000 Added 13.15%	258,200 $22.2 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $5.86 Million - $6.64 Million	70,200 Added 44.43%	228,200 $20.8 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $4.81 Million - $5.34 Million	67,000 Added 73.63%	158,000 $12.9 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $9.59 Million - $10.9 Million	-131,000 Reduced 59.01%	91,000 $7.55 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $17.2 Million - $19.4 Million	222,000 New	222,000 $20.2 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Merck & Co., Inc. Transaction History